LGC Buys High-Throughput PCR Company
Douglas Scientific has more than 100 employees. The acquisition adds automation and equipment expertise to LGC Genomics, which supplies DNA extraction and PCR consumables and products, including services. LGC Genomics has exclusively distributed Douglas Scientific’s ArrayTape Platform in selected regions since 2011.
London, UK and Alexandria, MN 4/6/16—Life sciences and measurement firm LGC has acquired a majority stake in Douglas Scientific from Kingdom Enterprises. Douglas Scientific supplies high-throughput PCR and qPCR platforms, and Array Tape consumables. “Customers will benefit from the unique synergies between our two organizations, including: combined workflow solutions for extraction, genotyping and gene expression with optimized application protocols utilizing LGC proprietary KASP and Klearkall PCR mastermix reagents together with our Biosearch BHQ and BHQplus probes,” said Giulio Cerroni, managing director of LGC’s Genomics division. Kingdom Enterprises, a holding company of Douglas Machine, a supplier of automated packaging solutions for paperboard, corrugated and shrink film, continues to hold a minority interest.
